abstract BACKGROUND AND OBJECTIVE: Advanced understanding of modifiable predictors of health care use in pediatric chronic illness is critical to reducing health care costs. We examined the relationship between medication non-adherence and health care use in children and adolescents who have a chronic medical condition.
In 2010, the United States spent $2.6 trillion on health care, an increase of 3.9% from 2009, and 17.9% of its gross domestic product. 1 Hospital care and physician and clinical services (ie, emergency department [ED] visits, hospitalizations, and office visits, hereafter defined as "health care use") are the 2 largest components of health care spending, 2, 3 and accounted for over 50% of the growth in health care spending from 2009 to 2010. 1 Continued rising health care costs despite the recession, the increasing US national deficit, and the increasing percentage of US health spending financed by the government ($1.2 trillion, 45% of all US health spending) have prompted investigation of modifiable factors to reduce health care use and associated costs. 4 Although there is no single strategy for effectively controlling costs, researchers have begun to focus on the 83% of health care resources consumed by individuals who have a chronic medical condition. 4, 5 The number of children and adolescents diagnosed with a chronic medical condition has been steadily increasing over the past 20 years, 6 driven in part by increases in the prevalence of obesity 7 and asthma 8 as well as advances in medical care that increase survival (eg, cystic fibrosis, kidney transplant). 9, 10 Increases in the prevalence of chronic medical conditions have only increased the already disproportionate health care expenses accounted for by children and adolescents who have a chronic illness. 5, 11, 12 In 2000, children and adolescents with a special health care need made up 16% of youth but accounted for 53% of hospital days. 13 Consequently, targeting factors that influence health care use in this population may provide 1 of the greatest opportunities to reduce pediatric health care spending.
Non-adherence refers to a lack of correspondence between patient self-management behavior and medical or health advice 14 and significantly contributes to health care use in adults who have a chronic illness, [15] [16] [17] [18] accounting for an estimated 33% to 69% of adult hospital admissions and $100 to $300 billion in annual health care costs. 19, 20 Because much of the health care use attributable to non-adherence includes excess use of urgent care and hospitalizations for preventable complications, 16 it represents avoidable costs, an ideal target outcome for interventions aimed at reducing health care spending. As non-adherence is modifiable with intervention, 21 adult adherence promotion efforts have begun to focus on both improving health status and reducing health care use, resulting in programs that effectively decrease health care costs. 15 Efforts to contain pediatric health care costs could prove to be equally as effective as adult-focused interventions, but have not yet been examined despite the widespread nature of non-adherence in pediatrics. Approximately 63% of children and adolescents who have a chronic illness are prescribed medication, 22 but 50% to 88% of children and adolescents are non-adherent to their prescribed regimens. [23] [24] [25] As in adult samples, pediatric non-adherence may be a modifiable predictor of health care use and resulting health care costs. For example, an adolescent who has asthma may require hospitalization after failing to take his controller medication for several days and suffering an exacerbation. If his medical care included regular assessments of his adherence and adherence promotion efforts as necessary, this hospitalization and its associated costs may have been avoided. 16, 26 Understanding the impact of adherence promotion interventions on health care costs specific to pediatric populations is necessary given the numerous developmental factors that make pediatric adherence unique (ie, influence of adult caregivers and systems on adherence, evolution of illness burden with age, increasing autonomy for disease management) and the variations in health care systems and outcomes across the lifespan. For example, health care financing for over one-third of children and adolescents is provided by Medicaid and Children's Health Insurance Programs. 27 With inconsistencies in benefits and reimbursement rates between states, it is difficult to compare health care costs across pediatric and adult samples. Furthermore, given the more advanced disease course and higher likelihood of complications experienced by adults who have a chronic illness, the benefits in quality of life and cost savings resulting from pediatric prevention efforts are likely to be less visible in shortterm evaluations typically used with these populations. 28 An increased understanding of the relationship between non-adherence and health care use in pediatric populations presents an opportunity to examine a highly prevalent and modifiable (amenable to behavioral intervention) potential contributor to pediatric health care costs. Unlike other stable predictors of health care use (ie, gender, socioeconomic status), nonadherence can be modified with behavioral intervention, and thus is of clinical significance. If non-adherence contributes to pediatric health care use, there is the potential to have even greater impact on health care use than adult efforts, because long-term self-management behaviors are often developed in childhood and adolescence. 23 Specifically, promoting adherence in pediatric populations may have the potential to reduce short-term health care use as well as long-term health care use that may result from the increased morbidity associated with non-adherence. 23 Despite the potential significance, to our knowledge no studies have reviewed the extant literature with a targeted examination of the relationship between medication non-adherence and health care use in children and adolescents who have a chronic illness. This issue is timely as health care reform efforts and discussions regarding covered services and service delivery models (ie, fee for service versus permember, per month) move forward. We need to better understand how modifiable factors contribute to health care costs and value to identify relevant and significant priorities of health care reform. Application of findingswith adult populations would exclude many of the unique modifiable variables that impact pediatric adherence (ie, family functioning, caregiver involvement). 14 The purpose of this systematic review is to provide a comprehensive summary of the empirical studies examining the relationship between non-adherence and health care use in children and adolescents who have a chronic medical condition. Recommendations for advancing research in this field and policy implications are also discussed.
METHODS
The systematic review was conducted in accordance with the published guidelines presented in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement. 29 
Data Search
PubMed, PsycINFO, and CINAHL were searched in April 2013 for peerreviewed original research articles published in English before April 2013. The search strategy included a combination of Medical Subject Headings terms (eg, chronic disease, patient compliance,medicationadherence,health care costs, hospitalization, emergency service, ambulatory care) and key words (eg, adherence, non-adherence, self-management, compliance, treatment concordance, health care utilization, outpatient visit, emergency department, hospitalization, health care cost, service utilization, service use, health care use, cost, chronic illness, chronic care, chronic) (see Supplemental Information). To ensure all relevant articles were captured, an additional search was done replacing terms describing "chronic disease" with "diabetes," "asthma," or "HIV," effectively searching some of the most developed adherence literature bases in pediatrics (see Supplemental Information). The search did not include restrictions on publication date or study design.
Study Selection and Screening
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses 4-phase flow diagram detailing study selection is depicted in Fig 1. 29 The initial search resulted in 4519 records. After the removal of duplicates, we screened the abstracts of 4346 manuscripts. Of these, 73 manuscripts met the following inclusion criteria: (1) pediatric sample with a chronic illness; (2) original research article; and (3) mention of adherence and health care use or cost. We then reviewed full-text versions of these 73 manuscripts. We excluded studies that did not assess non-adherence and health care use, did not examine the relationship between these variables, or included participants with a mean age .18 years.
Data Extraction
One reviewer (Dr McGrady) completed data extraction from included articles by using a standardized data collection form. A second reviewer (Dr Hommel) checked the abstracted data for accuracy. Data retrieved from articles included: (1) identification of the manuscript (authors, year); (2) characteristics of participants (child age, child chronic illness, caregiver participating); (3) study design in accordance with published guidelines 30 (cohort, cross-sectional, case-control, or randomized clinical trial); (4) measure of non-adherence; (5) measure of health care use; and (6) relationship between non-adherence and health care use. In cases in which multiple measures of non-adherence or outcomes were used, all variables were included. Questions regarding inclusion or relevant data were resolved via discussion between authors.
Definitions of Variables

Measures of Medication Non-Adherence
Medication non-adherence was assessed using measures of varying validity and reliability, 31 including selfreport questionnaires, self-report structured interviews, electronic monitoring devices, prescription refill histories, and biochemical assays (see Table 1 ). The time period during which non-adherence was assessed ranged from 24 hours to 365 days. Of note, some measures included non-adherence threshold measurements with cutpoints. As these cut-points differed across studies, definitions of "good," "high," or "optimal" adherence presented in this manuscript are those provided by the authors of reviewed studies.
Measures of Health Care Use
To facilitate comparison across studies, we classified health care use data as ED visits, outpatient visits, hospitalizations, or "other" measures (eg, combined number of ED visits, outpatient visits, and hospitalizations) of health care use. Measures of health care use were obtained via caregiver self-report, review of the electronic REVIEW ARTICLE PEDIATRICS Volume 132, Number 4, October 2013medical record, or review of insurance databases.
Risk of Bias
To ascertain the reliability of the results of the included studies, the risk for bias was assessed by using the items from the Newcastle-Ottawa Quality Assessment Scale. 32, 33 The Newcastle-Ottawa Quality Assessment Scale is a valid and reliable measure developed to assess the quality of nonrandomized studies included in systematic reviews. High-quality studies are identified using a "star system," with more stars representing higher quality. Two of the 8 domains of study quality (representativeness of the cohort and outcome assessment method) were relevant to the included studies. We rated each study in accordance with published guidelines on these 2 domains.
RESULTS
Ten studies met all inclusion criteria and were included in this review (see Fig 1) . Nine of the studies included children and/or adolescents who had asthma, and 1 study included a sample of adolescents and young adults who had type 1 diabetes. Mean age of study participants ranged from 6.2 to 16 years. Study designs included prospective observational cohort (n = 4), cross-sectional analyses (n = 3), retrospective observational cohort (n = 2), and randomized-controlled trials (n = 1). Three studies used managed care organizations, Medicaid, or Children' s Health Insurance Programs to access population-level data (range of sample sizes, 1474-18 456). The other studies included data from single (n = 4; range of sample sizes, 63-150) or multiple hospitals/clinics (n = 3; range of sample sizes, 158-2960). Measures of adherence varied across studies and included pharmacy refill records (n = 5), self-report measures (n = 3; eg, "In the past 2 weeks, how many days would you guess that your child has forgotten to take his or her medicine?"), and electronic monitors (n = 2).
Medication Non-Adherence and ED Visits
Six of the 7 studies examining the relationship between medication nonadherence and ED visits in children and adolescents who had asthma found that greater non-adherence using multiple measures was related to more ED visits. Children and adolescents who had asthma who did not fill any prescriptions for antiinflammatory medications had a higher risk for an ED visit than those who filled at least 1 prescription. 34, 35 Furthermore, lower percentage of time during which children and adolescents possessed anti-inflammatory medications (medication possession ratio [MPR] = [number of days covered by dispensed medication/365] 3 100) was related to higher odds of an ED visit. 36 Consistent with these findings, a lower percentage of doses taken, as measured by electronic monitoring devices, was associated with increased ED visits. 37 In a study comparing groups of children who had asthma seen in the ED to those seen in asthma clinic, selfreported non-adherence was higher in those seen in the ED. 38 Similarly, caregiver report of more non-adherence was associated with more ED visits for children who had asthma. 39 In contrast, a third study using a self-report measure of adherence found no relationship between non-adherence and ED visits when included in a multivariate model. 40 Medication Non-Adherence and Outpatient Visits
Both of the studies examining medication non-adherence and outpatient visits found that non-adherence was associated with fewer asthma-related office visits. In a sample of children who had asthma, the fewer days a child possessed inhaled corticosteroids or leukotriene inhibitors, the less often asthma-related office visits occurred. 36 Similarly, children who had not filled a prescription for a controller medication in the past 3 months were less likely than children who had filled a prescription to have an asthma primary care physician visit. 35 
Medication Non-Adherence and Hospitalizations
Findings of the 5 studies examining medication non-adherence and hospitalizations were mixed and varied based on method of adherence measurement. Four of these studies included children who had asthma and 1 included adolescents and young adults who had type 1 diabetes. For children who had asthma, failing to fillanyprescriptionsforanti-inflammatory medication was associated with an increased risk for hospitalization. 34 However, when MPRs for inhaled corticosteroids were calculated and grouped, those with 20% to 49% MPR had increased odds of a hospital admission as compared with those with an MPR of 0% to 19%. 36 MPRs for leukotriene inhibitors were not associated with hospitalizations. 36 Caregiver self-reports of non-adherence to corticosteroids were associated with more hospitalizations in a sample of children who had asthma. 39 In another sample, however, a composite score comprised of asking caregivers yes/no questions related to their adherence to filling prescriptions, giving more/less medication than prescribed, and obtaining recommended devices yielded no relation to whether the child was hospitalized in the past 9 months. 41 In a sample of adolescents and young adults who had type 1 diabetes, nonadherence was associated with increased odds for admission for diabetic ketoacidosis and other diabetes-related complications. 42 
Medication Non-Adherence and Other Measures of Health Care Use
Similar to the aforementioned results linking non-adherence with more frequent ED visits, caregivers of children with higher levels of self-reported non-adherence also reported more frequent unscheduled asthma visits (defined as provider and ED visits). 41 Results of growth curve modeling analyses suggest that medication nonadherence may be associated not only with rates of health care use, but also changes in health care use patterns. 43 In a sample of African American children who had asthma, non-adherence was associated with greater increases in health care use over time than those demonstrated by groups of participants with better adherence. 43 The only study to directly examine costs related to non-adherence indicated that non-adherence was associated with lower per-member, per-month public insurance payments in a sample of children who had asthma. 36 As adherence to medication requires payment for prescriptions, Boylston Herndon et al found that non-adherent children had lower drugrelated costs than children with higher adherence levels. In this study, the costs saved by not filling prescriptions were more than the increased costs of visiting the ED or being hospitalized incurred by these participants.
Risk for Bias
Risk for bias as identified by the items from the Newcastle-Ottawa Quality Assessment Scale and the inclusion of confounding variables is presented in Table 1 . Three of the 10 studies (33%) included a cohort likely representative of the relevant pediatric population. Over three-quarters of studies (n = 8, 80%) used objective outcome measures.
DISCUSSION
Nine of the 10 studies reviewed (90%) demonstrated a relationship between medication non-adherence and increases in at least 1 health care use variable. Of note, the directionality of the relationship between medication nonadherence and health care use depended on the outcome of interest. The majority of studies examined reported that medication non-adherence was associated with more ED visits and hospitalizations.
The relationship between medication non-adherence and ED visits and hospitalizations is consistent with findings in adult samples 18, 44, 45 and suggests that there is potential to reduce the $1800 per child spent on hospital care in 2010. 46 Children and adolescents who were non-adherent suffered from more exacerbations and complications requiring medication attention and thus required more ED visits or hospitalizations.
Although non-adherence was linked with more ED visits and hospitalizations, it was also related to fewer outpatient visits. 35 31 Fourth, currently available methods can result in misleading findings, such as cost-savings associated with lower drug-related costs attributable to non-adherence. Researchers using relatively brief follow-up periods capture only the short-term drug cost savings realized from non-adherence and not the long-term, more costly consequences (eg, more frequent hospitalizations) of non-adherence. Thus, future research should address this methodologic issue by longitudinal designs that account for expected costs (eg, medication refills) versus unexpected costs (eg, ED visits) and follow participants for periods of time that allow for long-term consequences of non-adherence to be realized. Fifth, the generalizability of our findings to non-Western populations may be limited by our exclusion of non-English manuscripts. As the prevalence of non-adherence is a global concern, 15 more inclusive reviews should be considered.
Resources allocated to improving adherence are often fairly limited. In the current economic and political climate, however, increasing attention has been paid to novel approaches to improving health outcomes while reducing spending. Results of this review suggest that targeting non-adherence in children and adolescents who have a chronic illness may provide a unique opportunity to reduce health care use in a continually growing population. Consistent with the call for action proposed by the World Health Organization, 15 multidisciplinary efforts to promote adherence should be a priority for all medical providers and policy makers.
